APTO

Aptose Biosciences Inc.

APTO | NASDAQ Capital Market

0.279USD0.1088 %

Review Aptose Biosciences Inc.'s financial health, with detailed free cash flow data and upcoming trends.

Annual
Breakdown2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Current Assets
11.89 M
%-75.98
49.52 M
%-39.42
81.74 M
%-34.65
125.08 M
%26.64
98.77 M
%499.09
16.49 M
%39.42
11.82 M
%40.34
8.43 M
Non-Current Assets
1.09 M
%-27.39
1.51 M
%91.37
788 K
%-33.56
1.19 M
%-30.64
1.71 M
%345.31
384 K
%170.42
142 K
%-33.03
212.04 K
Current Liabilities
15.27 M
%24.30
12.28 M
%50.28
8.17 M
%19.99
6.81 M
%22.98
5.54 M
%98.60
2.79 M
%58.02
1.76 M
%34.03
1.32 M
Total Non-Current Liabilities
621 K
%-38.02
1 M
%771.30
115 K
%-78.50
535 K
%-47.08
1.01 M
%-23.12
1.31 M
0
0
Total Liabilities
15.89 M
%19.60
13.29 M
%60.28
8.29 M
%12.82
7.35 M
%12.17
6.55 M
%134.85
2.79 M
%58.02
1.76 M
%34.03
1.32 M
Other Liabilities
0
0
0
0
0
-1.31 M
0
0
Stockholders Equity
-2.9 M
%-107.69
37.74 M
%-49.16
74.24 M
%-37.57
118.92 M
%26.60
93.93 M
%567.04
14.08 M
%38.02
10.2 M
%39.35
7.32 M